Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T12:21:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T12:40:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:22:22.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:37.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and signaling restricted access to the study page.
    Difference
    17%
    Check dated 2026-09-20T20:31:46.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The status text changed from 'No Results Posted' to 'Results Submitted', indicating that results data have been submitted for the trial and are moving toward public posting.
    Difference
    0.1%
    Check dated 2026-09-06T19:15:38.000Z thumbnail image

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.